In contrast, a DL model can offer precise, AI-generated coding suggestions for adverse events and concomitant medications at up to 99% accuracy. The model can adapt to different scenarios, removing ...

Experts at the 2025 OCT DACH conference will dive into the potential of the European region amid a shifting clinical trial ...

At CDMI 2025, an expert discussed the challenges and potential solutions for adopting digital solutions in clinical trials.

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

Thermo Fisher (NYSE:TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data management firm at around $10B, the Financial Times reported, citing people ...

(Reuters) -Medical equipment maker Thermo Fisher is nearing an all-cash takeover of U.S-based Clario in a deal that could ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...